Similarly, cagrilintide is being developed by Novo Nordisk , primarily as part of the CagriSema combination, with regulatory submissions anticipated once Phase 3 data are fully analysed and published
doi: 10.1038/s41429-025-00850-7 [DOI] [PubMed] [Google Scholar] 18.Teskey G, Cao R, Islamoglu H, et al
Cell Communication and Signaling, 21 , Article 67
Bradley-Whitman and Lovell [135] reported that global levels of 5mC and 5hmC were significantly increased, whereas 2 intermediates (5-formylcytosine and 5-carboxylcytosine), in the demethylation steps, were significantly decreased
Etiology Type 1 diabetes (T1D) is caused by a complex interaction between genetic predisposition and environmental factors